Turn Therapeutics (TTRX) Total Liabilities (2024 - 2026)

Turn Therapeutics has reported Total Liabilities for 3 years, with the latest figure at $12.5 million in Q1 2026.

• For the quarter ending Q1 2026, Total Liabilities rose 1630.04% year-over-year to $12.5 million; the trailing twelve-month figure through Mar 2026 stood at $12.5 million (up 1630.04% YoY), and the FY2025 full-year result was $7.5 million, up 235.78% from the prior year.
• Total Liabilities for Q1 2026 stood at $12.5 million, up from $7.5 million in the prior quarter.
• The five-year high for Total Liabilities was $12.5 million in Q1 2026, with the low at -$818710.0 in Q1 2025.
• Average Total Liabilities over 3 years is $4.3 million, with a median of $3.0 million recorded in 2024.
• Year-over-year, Total Liabilities jumped 235.78% in 2025 and soared 1630.04% in 2026.
• Tracing TTRX's Total Liabilities over 3 years: stood at $2.2 million in 2024, then jumped by 235.78% to $7.5 million in 2025, then jumped by 67.57% to $12.5 million in 2026.
• The last three Total Liabilities figures came in at $12.5 million (Q1 2026), $7.5 million (Q4 2025), and $3.8 million (Q3 2025), per Business Quant data.

Peer Comparison